ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Journal and News Scan

Source: European Respiratory Journal
Author(s): Jordi Remon, Julia Bonastre, Benjamin Besse

This is an outstanding and provocative editorial comment concerning treatment costs of lung cancer based on an article published in the last issue of the European Respiratory Journal.  It reveals discrepancies in access to new therapies based on therapeutic targets due to molecular testing and treatment costs.

Source: Journal of Thoracic and Cardiovascular Surgery
Author(s): Biniam Kidane, Joanne Sulman, Wei Xu, Qin Quinn Kong, Rebecca Wong, Jennifer J. Knox, Gail E. Darling

In this multicenter study, baseline QOL was assessed in over 200 patients with stage II or III esophageal cancer who underwent induction therapy and surgery or definitive chemoradiotherapy.  Baseline QOL was related to survival independent of age, stage, histologic type, and treatment.  It is suggested that assessment of baseline QOL is a prognostic tool that can be used in shared decision making.

Source: Journal of Thoracic and Cardiovascular Diseases
Author(s): Masaya Sugimoto, Hirofumi Saiki, Akiko Tamai, Mitsuru Seki, Ryo Inuzuka, Satoshi Masutani, Hideaki Senzaki

The authors measured serum amino-terminal procollagen III (PIII) as a marker of myocardial fibrogenesis in patients undergoing the Fontan procedure for single ventricle circulation and in controls.  Patients with single venticle circulation had elevated PIII levels compared to controls.  Staged Fontan elements successively reduced PIII levels.   The levels of volume load and cyanosis were related to PIII levels.  Persisently elevated PIII levels were related to venticular stiffening.  PIII may be a useful marker of disease state and could indicate a therpeutic target.

Source: Journal of Thoracic and Cardiovascular Surgery
Author(s): Rakesh M. Suri, Joseph A. Dearani, Tomislav Mihaljevic, W. Randolph Chitwood Jr., Douglas A. Murphy, Alfredo Trento, Hoda Javadikasgari, Harold M. Burkhart, Wiley L. Nifong, Richard C. Daly, A. Marc Gillinov

This article summarizes the current status of robotic approaches to mitral valve repair.  The technique is suitable to all types of degenerative mitral valve disease, and the outcomes are similar to those for open repair. 

Source: Journal of Thoracic and Cardiovascular Surgery
Author(s): Mark Rodefeld

The author summarizes the challenges but tremendous potential of mechanical circulatory support for infants and children undergoing heart surgery.

Source: Journal of Cardiac Surgery
Author(s): Niv Ad, Sari D. Holmes, Linda Halpin, R.N., Deborah J. Shuman, Casey E. Miller, Deborah Lamont

This article examined the impact of gait speed, as a marker of frailty, on surgical outcomes in a group of 167 cardiac patients aged 65 years or older. The authors concluded that there was no relation between gait speed and outcome. 

Source: New York Times
Author(s): CHARLES ORNSTEIN

A hospital has agreed to pay a $2.2 million penalty for permitting the video-taping of two patients who did not consent to the filming. U.S. Federal regulators have also used the opportunity to clarify stipulations governing the filming of patients. 

 

Source: J Thorac Cardiovasc Surg
Author(s): Paparella D, Di Mauro M, Bitton Worms K, Bolotin G, Russo C, Trunfio S, Scrofani R, Antona C, Actis Dato G, Casabona R, Colli A, Gerosa G, Renzulli A, Serraino F, Scrascia G, Zaccaria S, De Bonis M, Taramasso M, Delgado L, Tritto F, Marmo J, Parolari A, Myaseodova V, Villa E, Troise G, Nicolini F, Gherli T, Whitlock R, Conte M, Barili F, Gelsomino S, Lorusso R, Sciatti E, Marinelli D, Di Giammarco G, Calafiore AM, Sheikh A, Alfonso JJ, Glauber M, Miceli A; GIROC Investigators.

In a large multi-center, propensity-matched study, Paparella et al found that antiplatelet therapy as opposed to oral anticoagulation therapy initiated after mitral valve repair as antithrombotic prophylaxis caused significantly less major bleeding, which also caused mortality to be less by a 5-fold than with anticoagulation therapy. 

Source: The New England Journal of Medicine
Author(s): Guyton RA, Smith LA

An editorial discussion of the impressive 10-year benefits of CABG for ischemic cardiomyopathy as found in the STICH trial.

Source: Annals of Thoracic Surgery
Author(s): Marco Ranucci, MD, Valeria Pistuddi, Ekaterina Baryshnikova, PhD (Biol), Dionisio Colella, MD, Paolo Bianchi, MD

These authors analyzed retrospectively the effect of postoperative fibrinogen level on bleeding after heart surgery in their database of 2,800 patients.   They found that serum fibrinogen levels lower than 220 mg/dl more than doubled the risk of postoperative bleeding.  

Is it time to standardize the measurement of postop fibrinogen in cardiac surgery?

Pages